GPT and COVID-19: In a study done by Cai et al., 76.3% of COVID-19 patients had abnormal liver tests (ALT, AST, AP, and total bilirubin), and in COVID-19, ALT and AST levels are transiently increased, and the mechanism through which liver dysfunction occurs is most likely through secondary liver damage rather than a direct insult [28].